BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35937944)

  • 21. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
    Tong H; Li T; Gao S; Yin H; Cao H; He W
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms for prediction of overall and cancer-specific survival in young breast cancer.
    Sun Y; Li Y; Wu J; Tian H; Liu H; Fang Y; Li Y; Yu F
    Breast Cancer Res Treat; 2020 Nov; 184(2):597-613. PubMed ID: 32886273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
    Jiang F; Wu C; Wang M; Wei K; Wang J
    Sci Rep; 2021 Feb; 11(1):3986. PubMed ID: 33597614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
    Ma JY; Liu Q; Liu G; Peng S; Wu G
    Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 7-gene signature predicts the prognosis of patients with bladder cancer.
    Tang F; Li Z; Lai Y; Lu Z; Lei H; He C; He Z
    BMC Urol; 2022 Jan; 22(1):8. PubMed ID: 35090432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
    Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
    J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3/HIF1A and EMT specific transcription factors regulated genes: Novel predictors of breast cancer metastasis.
    Hegde M; Daimary UD; Kumar A; Chinnathambi A; Alharbi SA; Shakibaei M; Kunnumakkara AB
    Gene; 2022 Apr; 818():146245. PubMed ID: 35074419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
    Zhang B; Wang Q; Fu C; Jiang C; Ma S
    Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
    Li S; Liu X; Chen X
    BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.